Clinical trials
Non-alcoholic Fatty Liver Disease trials in China with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 6 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 36 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Beijing Friendship Hospital | 2 |
| Nanfang Hospital, Southern Medical University | 2 |
| Xuanzhu Biopharmaceutical Co., Ltd. | 2 |
| Yan Bi | 2 |
| 1Globe Biomedical Co., Ltd. | 1 |
| Affiliated Hospital of Nantong University | 1 |
| Beijing Municipal Administration of Hospitals | 1 |
| Beijing Tsinghua Chang Gung Hospital | 1 |
| Chinese PLA General Hospital | 1 |
| Fangfang Zeng | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-alcoholic Fatty Liver Disease | 36 |
| Fatty Liver | 7 |
| Liver Cirrhosis | 5 |
| Obesity | 5 |
| Diabetes Mellitus, Type 2 | 3 |
| Cardiovascular Diseases | 2 |
| Glucose Metabolism Disorders | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Atherosclerosis | 1 |
| Chemical and Drug Induced Liver Injury | 1 |
Trials
Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.